---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000462"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:43:55.526296+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outset Medical reports Q4 2022 expected revenue ~$31.5M; guides FY2023 revenue $140-150M

## Summary
- Q4 2022 expected revenue ~$31.5M (+13% QoQ); FY2022 expected revenue ~$115M (+12% YoY).
- Installed base of Tablo systems grew 54% YoY to ~4,000; home provider units doubled to ~800.
- FY2022 non-GAAP gross margin expected in mid-teens; FY2023 guidance: ~20% full year, mid-20% exit Q4.
- 2023 revenue guidance $140M-$150M (22-30% growth over 2022 expected revenue).

## SEC filing metadata
- accession: 0000950170-23-000462
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017023000462/0000950170-23-000462-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017023000462/om-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000462
- JSON: https://secwatch.observer/filing/0000950170-23-000462.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000462.txt

## Key facts
- Earnings Releases
  Outset Medical, Inc. updated its 2023 guidance (initiated).
  - Period: 2023
  - Guidance: initiated
  - Result: guidance update
  source text: Outset expects 2023 revenue to be between $140 million to $150 million, growing approximately 22% to 30% over expected revenue for 2022. Non-GAAP gross margin is expected to expand to approximately 20% for the full year 2023 and exit the year in the mid-20% range for the fourth quarter of 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023000462/0000950170-23-000462-index.htm
- Earnings Releases
  Outset Medical, Inc. reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue approximately $31.5 million.
  - Period: the fourth quarter and fiscal year ended December 31, 2022
  - Revenue: approximately $31.5 million
  - Result: preliminary results
  source text: revenue for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter and Year End Highlights • Revenue in the fourth quarter is expected to be approximately $31.5 million, a 13% increase compared to $27.8 million in the third quarter of 2022 • Revenue for 2022 is expected to be approximately $115 million, a 12% increase compared to $102.6 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023000462/0000950170-23-000462-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.